Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nucmito Pharmaceuticals Co. Ltd.

Clinical trials sponsored by Nucmito Pharmaceuticals Co. Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug NM6603 enters first human tests for advanced cancers Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Terminated 1

New drug NM6603 enters first human tests for advanced cancers

Disease control Recruiting now

This early-stage study tests a new drug called NM6603 in about 30 adults with advanced solid tumors (mainly colorectal or triple-negative breast cancer) who have run out of standard options. The main goal is to find the safest dose and check how the drug moves through the body. P…

Phase 1 • Sponsor: NucMito Pharmaceuticals Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC